Abstract
Rajata Bhasma (RB) is an Ayurvedic formulation and used for the treatment of liver disorders. Till date scientific validation according to modern tool of RB has been not performed. Hence it was planned to evaluate the hepatoprotective activity of RB in CCl4 induced liver cirrhosis rats. The different formulation RB1 (9 puta) and RB2 (17 puta) were prepared by following classical methods. The SGOT, SGPT, ALP, ACP, total bilirubin and direct bilirubin in blood significantly enhance in CCl4 treated rats compared to normal group rats. After treatment with the different doses of RB1 (50 mg/kg and 100 mg/kg) and RB2 (50 mg/kg and 100 mg/kg) significantly decreased the CCl4 induced alteration in SGOT, SGPT, ALP, ACP, total bilirubin and direct bilirubin in blood. The RB1 and RB2 treated rats significantly increased the level of catalase, glutathione peroxidase, superoxide dismutase enzyme, whereas lipid peroxidation was decreased, when compared to CCl4 treated group rats. Theses property confirmed the antioxidant properties of RB. The findings suggest that hepatoprotective activity of RB may be due to free radical scavenging property.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call